Pathological investigation of thromboembolism in the obstetrics and gynecology disorder

Not Applicable

• Conditions: Venous Thromboembolism

• Registration Number: JPRN-UMIN000020759
• Lead Sponsor: Department of Obstetrics and Gynecology, Kyushu University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-01-27
• Study Completion: 2018-04-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Female
• Target Recruitment: 600

Inclusion Criteria

Not provided

Exclusion Criteria

Group A:Patients with the history of thromboembolism 1.Patients with pregnant. 2.Patients with post partum within 28 days.Patients within 28 days after surgery (exclude surgeries less than 30 minutes). Group B:Patients without the history of thromboembolism 1.Patients with pregnant. 2.Patients with post partum within 28 days.Patients within 28 days after surgery (exclude surgeries less than 30 minutes). 4.Patients with anti coagulant therapy (eligible if low-molecular-weight heparin is available more than 2 weeks before collecting blood). 5.Patients who initiated the sex steroid hormone therapy within 3 months. Group C:Normal female subjects The information from human genome/gene analysis research"Pathological Investigation of the factor of thromboembolism peculiar in Asian" in Faculty of Nutritional Science,Nakamura Gakuen University is secondarily used. 1.Patients with hormonal therapy. 2.Patients with pregnant. 3.Patients with malignant disease. 4.Patients with anti coagulant therapy (eligible if low-molecular-weight heparin is available more than 2 weeks before collecting blood).

Study & Design

• Study Type: Observational
• Study Design: Not specified